Literature DB >> 25762373

Contribution of the Runx1 transcription factor to axonal pathfinding and muscle innervation by hypoglossal motoneurons.

Masaaki Yoshikawa1,2, Mizuki Hirabayashi2, Ryota Ito2, Shigeru Ozaki2, Shin Aizawa1, Tomoyuki Masuda2, Kouji Senzaki2, Takashi Shiga2.   

Abstract

The runt-related transcription factor Runx1 contributes to cell type specification and axonal targeting projections of the nociceptive dorsal root ganglion neurons. Runx1 is also expressed in the central nervous system, but little is known of its functions in brain development. At mouse embryonic day (E) 17.5, Runx1-positive neurons were detected in the ventrocaudal subdivision of the hypoglossal nucleus. Runx1-positive neurons lacked calcitonin gene-related peptide (CGRP) expression, whereas Runx1-negative neurons expressed CGRP. Expression of CGRP was not changed in Runx1-deficient mice at E17.5, suggesting that Runx1 alone does not suppress CGRP expression. Hypoglossal axon projections to the intrinsic vertical (V) and transverse (T) tongue muscles were sparser in Runx1-deficient mice at E17.5 compared to age-matched wild-type littermates. Concomitantly, vesicular acetylcholine transporter-positive axon terminals and acetylcholine receptor clusters were less dense in the V and T tongue muscles of Runx1-deficient mice. These abnormalities in axonal projection were not caused by a reduction in the total number hypoglossal neurons, failed synaptogenesis, or tongue muscles deficits. Our results implicate Runx1 in the targeting of ventrocaudal hypoglossal axons to specific tongue muscles. However, Runx1 deficiency did not alter neuronal survival or the expression of multiple motoneuron markers as in other neuronal populations. Thus, Runx1 appears to have distinct developmental functions in different brain regions.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  CGRP; Runx; axonal projection; hypoglossal neuron; transcription factor

Mesh:

Substances:

Year:  2015        PMID: 25762373     DOI: 10.1002/dneu.22285

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  6 in total

1.  Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.

Authors:  Louis R Ghanem; Andrew Kromer; Ian M Silverman; Xinjun Ji; Matthew Gazzara; Nhu Nguyen; Gabrielle Aguilar; Massimo Martinelli; Yoseph Barash; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

2.  Diverse physiological properties of hypoglossal motoneurons innervating intrinsic and extrinsic tongue muscles.

Authors:  J C Wealing; M Cholanian; E G Flanigan; R B Levine; R F Fregosi
Journal:  J Neurophysiol       Date:  2019-09-18       Impact factor: 2.714

3.  Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis.

Authors:  Alexandre Henriques; Vincent Croixmarie; Alexandra Bouscary; Althéa Mosbach; Céline Keime; Claire Boursier-Neyret; Bernard Walter; Michael Spedding; Jean-Philippe Loeffler
Journal:  Front Mol Neurosci       Date:  2018-01-04       Impact factor: 5.639

4.  Molecular Characterization of Down Syndrome Embryonic Stem Cells Reveals a Role for RUNX1 in Neural Differentiation.

Authors:  Tomer Halevy; Juan-Carlos Biancotti; Ofra Yanuka; Tamar Golan-Lev; Nissim Benvenisty
Journal:  Stem Cell Reports       Date:  2016-09-08       Impact factor: 7.765

5.  Macrophage-Mediated Glial Cell Elimination in the Postnatal Mouse Cochlea.

Authors:  LaShardai N Brown; Yazhi Xing; Kenyaria V Noble; Jeremy L Barth; Clarisse H Panganiban; Nancy M Smythe; Mary C Bridges; Juhong Zhu; Hainan Lang
Journal:  Front Mol Neurosci       Date:  2017-12-11       Impact factor: 5.639

6.  Quiescence of adult oligodendrocyte precursor cells requires thyroid hormone and hypoxia to activate Runx1.

Authors:  Yasuhito Tokumoto; Shinpei Tamaki; Yasuaki Kabe; Keiyo Takubo; Makoto Suematsu
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.